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1. Introduction 
Chronic liver diseases result in fibrosis ultimately leading to cirrhosis, a liver end stage 
disease with high mortality and life threatening complications such as hepatocellular 
carcinoma. Thus far, no treatment options exist to cure and stop fibrosis progression except 
organ replacement by liver transplantation. This clinically unsatisfactory situation justifies 
the enormous interest in quantifying and monitoring fibrosis progression. Though liver 
biopsy remains the gold standard for assessing liver fibrosis, non invasive procedures are 
being developed for many years to overcome its complications (Bravo et al. 2001), sampling 
error and interobserver variability (Abdi et al. 1979; Bedossa et al. 2003; Cadranel et al. 
2001). Fibrosis and activity marker scores based on several blood parameters from a simple 
blood test have been developed to assess liver fibrosis and activity as obtained by liver 
biopsy Many efforts have been invested to identify serum markers that allow the diagnosis 
of cirrhosis from simple blood tests (Poynard et al. 2004). However those scores are indirect 
and reflect the fibrogenetic activity. Thus they do not correlate with the absolute amount of 
fibrotic tissue within the liver. 
It is now well established that fibrosis increases liver stiffness. Liver palpation (Fig. 1) is a 
routine medical practice that has been used since the beginning of medicine to assess liver 
stiffness. Though, palpation suffers from major limitations: it is highly subjective, very 
operator dependent and sometimes even impossible to perform. Recently, quantitative 
elastography emerged as a means to assess liver fibrosis non-invasively. Nowadays 
Vibration-Controlled Transient Elastography (VCTE™) is by far the most clinically 
validated quantitative elastography technique and VCTE™ based device, Fibroscan® 
(Echosens, France), has emerged as the reference tool for liver stiffness measurement. As a 
fact, Fibroscan® is more and more used in routine clinical practice as an alternative method 
to liver biopsy in patients with chronic liver diseases. 
The chapter is organized as follows: Section 2 covers quantitative elastography; the main 
quantitative elastography techniques are described with a strong focus on the most clinically 
validated technique: VCTE™. Fibroscan® device is described in Section 3; the examination 
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procedure is described. Advantages and limitations of the device are detailed. Applications 
of VCTE™ in hepatology are described in Section 4. The role of liver stiffness as a clinically 
relevant parameter will be pointed out. In Section 5, the pressure-stiffness-fibrosis sequence 
hypothesis is addressed. Eventually, discussion and conclusion are drawn in Section 6 and 
Section 7, respectively. 
 
 
Fig. 1. Liver hand palpation: “The living are soft and yielding; the dead are rigid and stiff”, 
Lao Tzu, (6th century BCE). 
2. Quantitative elastography  
2.1 Elastography techniques 
It was a matter of time to see the development and emergence of sophisticated techniques 
such as elastography to quantitatively and non-invasively measure liver stiffness. 
Elastography is a recent field of research that started in the 80s to propose a reproducible 
and operator-independent alternative technique to hand palpation. Elastography techniques 
may be divided into two groups: qualitative elastography and quantitative elastography.  
Qualitative elastography is now widely available on ultrasound scanners, it provides a 
qualitative color image that gives an interpretation of stiffness without providing any 
number. Basically, while the operator moves the ultrasound transducer at the skin surface of 
the body, the scanner measures the quasi static displacements within the tissues. A map 
representing the inverse of the displacement is displayed usually in color: the larger the 
displacement, the softer the tissue. While this technique may be helpful in radiology to 
identify focal lesions, it is definitively not adapted to quantify stiffness. 
Quantitative elastography techniques rely on the use of low frequency shear waves. Indeed 
the velocity of these mechanical waves is directly related to the stiffness. Thus all 
quantitative elastography techniques combine a means to generate shear waves and an 
imaging technique to measure the propagation of the generated shear waves. 
2.2 Physics of elastography 
From a physical and mechanical point of view, stiffness can be defined as the shear 
modulus, µ, or the Young’s modulus, E. These moduli describe the mechanical response of a 
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medium under shear stress and longitudinal stress, respectively. The theory of linear 
elasticity is based on this relationship between stress and strain and states that the 
deformation of a material is directly proportional to the applied stress, σ = Eε, where σ is the 
stress applied to the material, and ε is the strain induced in the material. The Young’s 
modulus E is expressed in kilopascals (kPa) and represents the resistance of material to 
deformation. This law, known as Hooke’s law, gives the relationship between the strain ε, 
the Young’s modulus and the stress σ. A rod, length L, of elastic material can be seen as a 
linear spring. Under a stress σ, it will experience an extension ΔL: 
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The relationship between the Young’s modulus E, the Poisson coefficient υ and the Lamé 
coefficients λ and µ (also known as compression and shear moduli), is given by: 
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Biological tissues are mainly composed of water. The compression modulus λ is several 
Giga Pascal; it is thus very large compared to the shear modulus of soft biological tissues 
(several kilo Pascal) (Sarvazyan et al. 1995). With λ >> µ, it yields that υ ≈ 0.5 which is 
characteristic of a quasi-incompressible medium. Eventually, in soft medium, the 
Young‘s modulus E simplifies to: 
 3E µ  (2.3) 
Interestingly, under some simplification hypothesis, the shear modulus can be deduced 
from the shear wave velocity, Vs, and the mass density, ρ: 
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Since the soft body tissues mass density is almost constant (1000 kg/m3), the 
Young‘s modulus E can be obtained by measuring the velocity of shear waves. Thus shear 
waves are the foundation of quantitative elastography techniques. 
2.3 Background of quantitative elastography 
Quantitative elastography techniques, also called dynamic elastography techniques, have 
the advantage of allowing a quantitative imaging and better resolution than the static 
elastography techniques. However, they require more complex equipment for the 
generation of shear waves (monochromatic, transient) and imaging devices (ultrafast 
ultrasound, magnetic resonance imaging) able to measure shear wave induced displacement 
with a high resolution. There are basically two groups of quantitative elastography 
techniques depending on the shear wave generation method: remote generation using 
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radiation force and mechanical vibration. The shear wave frequency content may also be 
different: harmonic or transient.  
In transient elastography techniques, the propagating shear wave results from a transient 
(impulsive or short tone burst) excitation of the tissue. Indeed, an important feature of 
transient elastography techniques is that the vibration be transient to avoid reflections and 
interferences occurring within the tissues. The transient shear wave travels through the 
tissues within tens of milliseconds which implies that the ultrasound-based imaging 
modality be ultrafast to follow its propagation. Harmonic elastography techniques are using 
a continuous vibration at a fixed frequency. Several quantitative elastography techniques 
(see Table 1) were proposed to assess liver stiffness as a marker of pathological state. 
Advantages and limitations of quantitative elastography techniques are summarized in 
Table 2. 
 
 Imaging modality 
Shear wave generation 
mode 
Frequency
Vibration-Controlled 
Transient Elastography 
(VCTE™) 
Ultrasound 
Mechanical vibration 
Transient 
Fixed 
50 Hz 
Magnetic Resonance 
Elastography 
(MRE) 
Magnetic resonance 
imaging 
Mechanical vibration 
Harmonic 
Fixed 
60 Hz 
Acoustic Radiation  
Force Impulse (ARFI) 
Ultrasound 
Radiation force 
Transient 
Wideband 
Supersonic Shear  
Imaging (SSI) 
Ultrasound 
Radiation force 
Transient 
Wideband 
Table 1. Quantitative elastography techniques for liver stiffness measurement. 
 
 Advantages Limitations 
Vibration-Controlled 
Transient Elastography 
(VCTE™) 
Ease of use 
Highly standardized 
Controlled shear frequency 
Transient shear wave 
Large clinical validation 
Ascites 
Magnetic Resonance 
Elastography 
(MRE) 
Controlled shear frequency 
Penetration depth 
2D stiffness map 
Cost 
Acoustic Radiation  
Force Impulse (ARFI) 
Image guidance 
Transient shear wave 
Absence of shear wave control 
High intensity ultrasound 
Penetration depth 
Limited clinical validation 
Supersonic Shear  
Imaging (SSI) 
Image guidance 
Transient shear wave 
Absence of shear wave control 
High intensity ultrasound 
Penetration depth 
Absence of clinical validation 
Table 2. Advantages and limitations of quantitative elastography techniques. 
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2.3.1 Radiation force based elastography 
Radiation force based elastography uses high intensity ultrasound beams to induce 
displacements and tissue heating inside the liver remotely. Acoustic radiation force is 
applied to absorbing and/or reflecting materials in the propagation path of acoustic waves. 
This phenomenon is caused by a transfer of momentum from the acoustic wave to the 
propagation medium. The spatial distribution of the radiation force field is determined by 
both the acoustic excitation parameters and the tissue properties.  
ARFI technique (Nightingale et al. 2003; Palmeri et al. 2008) involves the mechanical 
excitation of tissue using localized, focused, impulsive radiation force excitations. This 
results in shear-wave propagation away from the region of excitation. The mechanical 
excitation occurs along the acoustic wave propagation path and within the focal region of 
the acoustic beam. The resulting displacement response is ultrasonically tracked through 
time using an abdominal ultrasound transducer combined with a dedicated ultrasound 
scanner. Direct inversion methods are then applied to estimate the associated shear 
velocity.  
Supersonic shear imaging (Bercoff et al. 2004; Muller et al. 2009) relies on the use of 
radiation force and a high frame rate ultrasound scanner (Sandrin et al. 2002). The medium 
is illuminated by a supersonic Mach cone: ultrasounds are focused successively at different 
increasing depths. The different spherical waves generated by each focus then interfere 
along a Mach cone in which the source is spreading faster than the shear wave generated 
and creates a plane wave front in the imaging plane. The ultrasound imaging system is then 
used to visualize the entire imaging plane with a good temporal resolution in a single 
acquisition typically 5000 to 20000 frames per second. Maps of the Young’s modulus are 
estimated by inverse problems from the time of flight of the shear wave front.  
Generating shear waves within the liver using radiation force requires high intensity 
ultrasound beams which induce liver tissue heating. Thermal safety issues related to 
incident radiation force pulses have been studied (Fahey et al. 2006; Palmeri & Nightingale 
2004). It required the development of special cooling time sequences to prevent overheating 
of liver tissues. As a consequence of the relative low energetic transfer efficacy, the 
amplitude of the remotely induced displacements remains low and the penetration depth of 
radiation force based elastography technique is thus limited. 
2.3.2 Mechanical vibration based elastography 
Mechanical vibration based elastography techniques are using a mechanical vibrator to 
induce shear waves into the body. In Magnetic Resonance Elastography (MRE) (Muthupillai 
et al. 1995), a nuclear magnetic resonance imaging (MRI) method is used for quantitatively 
mapping the physical response of the tissues to an excitation of low frequency typically 
between 50 Hz and 80 Hz (Klatt et al. 2006; Rouviere et al. 2006). MRE showed promising 
results especially for 2D mapping of tissue stiffness.  
Vibration-Controlled Transient Elastography (Castera et al. 2005; Sandrin et al. 2003; 
Sandrin et al. 2002; Ziol et al. 2005) is based on a single ultrasound transducer mounted on 
the axis of a mechanical actuator (Fig. 2). The ultrasound transducer (3.5 MHz) is used in 
pulse-echo mode to measure the displacements induced in a medium by the propagation of 
a low-frequency (50 Hz) shear wave. Interestingly the low frequency shear wave and the 
ultrasound are generated by the same piston-like transducer. The ultrasound beam 
coincides with the vibrator axis. Under the assumption of homogeneity, the symmetry 
considerations impose that the displacements on the axis of the transducer be purely 
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longitudinal. Diffraction effects from the piston-like transducer result in longitudinally 
polarized shear wave on the axis of symmetry (Sandrin et al. 2004). The displacements 
induced by the shear wave in the medium are measured using cross-correlation of 
successive ultrasound lines acquired at high frame rate. A spatial-temporal strain map is 
computed from the recorded displacements. The shear wave speed is calculated based on 
the slope of the wave front visualized in the strain map.  
 
 
Fig. 2. The low frequency shear wave (blue) and the ultrasound beams (red) are generated 
by the same piston-like transducer. Under the assumption of homogeneity, the symmetry 
considerations impose that the displacements on the axis of the transducer be purely 
longitudinal (white arrow).  
This technique is implemented in a standalone clinical device: Fibroscan®. It is the unique 
device that does not require integration into a conventional imaging system. Fibroscan® 
device is detailed in the next section. 
2.4 The importance of the vibration control in quantitative elastography 
The proper use of shear wave velocity analysis for clinical diagnosis requires the control of 
various physical parameters and in particular the control of the vibration to ensure an 
accurate, reliable and reproducible assessment of tissue stiffness. The control must be done 
on the shape, frequency and amplitude of the vibration. Of course, in VCTE, the amplitude 
of the vibration may be adapted to the morphology of the patients to increase the 
penetration depth of the shear wave. 
Furthermore, as stiffness value depends on shear wave frequency, the shape of the vibration 
must be controlled to obtain a consistent measurement that can be used for diagnostic 
purposes whatever the mechanical properties of the organ under investigation or the 
etiology of the patient. Provided that the shape of the vibration be constant, a reference 
frequency is obtained and a comparison of the shear wave propagation parameters can be 
performed independently of the organ conditions, etiology, patient and operator.  
2.5 The difficult process of liver stiffness measurement standardization  
The development and clinical validation of non-invasive methods for assessing liver fibrosis 
in patients with chronic liver diseases were eased by the fact that liver biopsy is not a perfect 
Mechanical
actuator 
Ultrasound 
transducer 
Tissues
Shear wave 
US beam 
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gold standard. However, standardization of elastography procedures is a challenging aspect 
of the success of elastography in the medical field and more precisely in hepatology. 
Radiation force based elastography techniques such as ARFI and SSI are attractive 
techniques since they are intrinsically image-guided and do not require the use of an 
external vibrator. Actually these attractive aspects of the technology may result in significant 
loss of performances.  
As a matter of fact, using an image guided system in which the operator has a full freedom 
of choice of the region of measurement will increase the operator dependency of the 
technique. While VCTE™ may look less sophisticated, it is based on a highly standardized 
procedure that can be followed not only by physicians but also by nurses. A short training is 
required before using Fibroscan®. This standardization favors the consistency of the results 
obtained whatever the operator, the studied population and the etiology of the patients.  
Shear waves remotely generated using radiation force are wide band with frequencies 
ranging from 100 Hz to 500 Hz. Indeed with radiation force, the frequency of the shear 
waves can not be controlled precisely. Thus the frequency content of the generated shear 
wave will vary as a function of parameters such as the acoustic attenuation, the nature of 
reflecting materials, the mechanical properties of the tissues through which the ultrasound 
and shear waves travel, the depth of the region of measurement, etc. Some of these 
parameters are obviously etiology-dependent. As a consequence, measured stiffness will 
vary. Moreover, it is now well described that liver stiffness increases when the shear wave 
frequency increases (see Fig. 3). Thus, the higher the frequency is, the higher the measured 
stiffness will be. 
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Fig. 3. Preliminary result: elastic modulus of a fresh pig liver sample as a function of 
frequency (courtesy of RheoLution inc). 
Eventually, though a direct conversion of liver stiffness values measured with transient 
elastography techniques based on radiation force and mechanical vibration is tempting, this 
task might be a very challenging task. Indeed, theoretically Young’s modulus as provided 
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by VCTE™ could be deduced from the shear velocity as measured by radiation force-based 
technique (ARFI, SSI, etc.). However, this relationship is only valid at a given frequency: 
    23 SE f V f  (2.6) 
As a matter of fact, while shear wave frequency in VCTE™ is 50 Hz, shear wave frequency 
using radiation force is not controlled. Thus, as the frequencies may be significantly 
different with these techniques, a direct conversion of radiation-force-based shear wave 
velocity to VCTE™ Young’s modulus is not possible. The Young’s modulus obtained with 
VCTE™ and radiation-force based elastograhy will differ. Therefore liver stiffness 
thresholds used for clinical decision support will have to be reevaluated. 
The success of VCTE™ and the good performances reported in many studies all over the 
world is certainly due to its high standardization and high control of the shear wave shape. 
3. Fibroscan® device 
In this Section, the Fibroscan® device is described from a technical point of view. The 
operating principle is detailed with appropriate figures. Tables are included to provide 
parameters of the different probes available associated with measurement depths, operating 
ultrasound frequency, probe diameter, etc. A list of the special controls used in the Fibroscan® 
to ensure high performances is included. The examination procedure is described. 
3.1 The device 
Transient elastography measures shear wave velocity and thus determines tissue stiffness 
by using ultrasound to follow the propagation of a low frequency shear wave generated in a 
tissue by an external vibrator (Sandrin et al. 2002; Ziol et al. 2005).  The Fibroscan® (Fig. 4) is 
composed of an integrated computer and dedicated electronics for ultrasound emission end 
reception, vibrator command and signal processing.  
 
Fig. 4. The Fibroscan® and its M-probe. 
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The Fibroscan® probe contains an ultrasonic transducer used both as receiver and emitter 
which is mounted on a mechanical vibrator to generate a low frequency (50 Hz) shear wave. 
During the propagation of the low frequency shear wave, the radiofrequency (RF) data are 
acquired at a repetition frequency of 6000 Hz. The displacements induced in the medium are 
computed from the RF data using an autocorrelation method and derived versus depth in 
order to provide a strain rate image called elastogram (Fig. 5(c)). Analysis of the strain 
image yields the shear wave velocity and thus elasticity using the formula E = 3ρVs² where 
E, ρ = 1000 kg/m3, and Vs are the Young’s modulus, the mass density and the shear wave, 
respectively. In order to compute the shear wave velocity, a time-of-flight algorithm is used 
(Sandrin et al. 2003). The system enables to measure stiffness values (Young’s modulus) 
between 1.5 kPa and 75 kPa.  
 
 
                                   (a)                     (b)                                           (c) 
Fig. 5. (a) TM-mode, (b) A-mode and (c) elastogram images. The elastogram is a 2D 
graphical representation of the strain rates as a function of depth and time. The slope of the 
shear wave is represented by a white dotted line. 
As shown in Table 3, four types of examination with specific depth and ultrasound 
frequency are available according to the morphology of the patient: skin-capsule distance 
(SCD) and thoracic perimeter (TP). 
 
Probe Exam.Type Criteria Examination depth Frequency 
S 
Small 1 (S1) TP ≤ 45 cm From 15 mm to 40 mm 
5 MHz 
Small 2 (S2) 45 cm < TP ≤ 75 cm From 20 mm to 50 mm 
M Medium (M) 
75 cm < TP ≤ 110 cm 
and SCD < 2.5 cm 
From 25 mm to 65 mm 3.5 MHz 
XL XL 2.5 cm ≤ SCD < 3.5 cm From 35 mm to 75 mm 2.5 MHz 
Table 3. Fibroscan® examination parameters. 
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3.2 Examination procedure 
During the examination, the patient is lying in dorsal decubitus and the right arm in 
maximal abduction so as to enlarge the intercostals space in which the probe is placed 
(Fig. 6). The ribs play an important role since they prevent the application of large 
pressure on the liver by the probe. Indeed, biological tissues have a non linear elastic 
behavior when they are submitted to large strains. This nonlinearity would result in a 
biased measurement of the stiffness. This phenomenon also explains why elasticity 
measurements cannot be performed on the left lobe of the liver which is not protected by 
the ribs. 
 
 
Fig. 6. During Fibroscan® examination, the patient is lying in dorsal decubitus and the right 
arm in maximal abduction so as to enlarge the intercostals space in which the probe is 
placed. 
The probe should be placed between the rib bones opposite to the right lobe of the liver in 
the middle of the parenchyma far from the border of the liver. The measurement point 
should actually be similar to the location where the liver biopsy would be performed. 
Measurements performed too close to the borders the liver stiffness should be avoided as 
they will be overestimated. 
The Fibroscan® device provides A-mode and M-mode images which should be used to 
find a liver portion suitable for the examination (Fig. 7). This liver area should be at least 
60 mm deep and free of large vascular structures. In the case of a standard examination, 
the stiffness measurements are performed between 25 mm and 65 mm below the skin 
surface. The force applied by the probe on the skin is controlled during the whole 
examination and must be comprised between 4 N and 8 N in order to trigger a stiffness 
measurement. 
During the examination, the operator should be careful about keeping the probe 
perpendicular to the skin surface or the liver stiffness may be overestimated (Fig. 8). The 
perpendicularity along both axes should be checked by looking at the probe. The operator 
should also check on the A-mode and TM-mode that the area is homogeneous and free of 
vessels structures (Fig. 9). 
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                                (a)                            (b) 
Fig. 7. The operator uses (a) TM-mode and (b) A-mode images to localize the 
measurement point. TM-mode represents the ultrasonic amplitude in log scale as a 
function of depth and time. A-mode is the real time ultrasonic line amplitude in log scale 
as a function of depth. 
 
 
Fig. 8. During the examination, the operator should be careful about keeping the probe 
perpendicular to the skin surface or the liver stiffness may be overestimated. 
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Fig. 9. The good window of acquisition is localized using A-mode and TM-mode displays. 
When all the conditions mentioned above are met, the operator can trigger a 
measurement. An acquisition is almost instantaneous; it lasts a tenth of second. The 
software automatically rejects elastograms not fulfilling quality criteria and if the 
measurements are invalid, no result is displayed. The result of the examination is the 
median of all valid stiffness measurements within the current examination. The Inter 
Quartile Range (IQR) of all valid measurements and the success rate are also computed. 
Echosens recommends that a minimum of 8 valid measurements be obtained to get a 
consistent liver stiffness estimate. 
Fibroscan® examination typically lasts between 2 and 5 minutes with recent devices. The 
liver explored volume by VCTE can be roughly approximated to be a cylinder of length 
40 mm and diameter 10 mm (the actual value depends on the shear wavelength and 
examination type). This volume is 200 times larger than a 20 mm long and 1 mm diameter 
biopsy specimen. 
Main limitations of Fibroscan® are the presence of ascites and obesity. Actually shear waves 
do not propagate through liquids. Thus Fibroscan® examination fails in some patients with 
ascites. However this limitation is counter balanced by the fact that ascites is already in itself 
an indication of liver pathological state. Thick subcutaneous tissues can result in a strong 
aberration of ultrasound and/or shear waves. As a result, it may be impossible to acquire 
enough valid measurements with Fibroscan® in some obese patients. However, a new 
probe, called XL probe, is now available to overcome this limitation. XL probe measures 
60 % of the patients not measured with M probe (de Ledinghen et al. 2010). 
4. Applications in hepatology 
A review of literature is made. In this review, the use of liver stiffness measured with 
Fibroscan® is studied for diagnosis, prognostic, prognosis and treatment follow-up 
purposes.  
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4.1 Repeatability and reproducibility 
Several groups have reported that liver stiffness measurements using Fibroscan® are 
repeatable and reproducible. The intra operator variability has been assessed (Boursier et al. 
2008; Fraquelli et al. 2007) with intra-class correlation coefficient of 0.94 and 0.98 on 20 and 
200 patients, respectively. The same publications as well as (Huwart et al. 2006) also 
evaluated the inter operator reproducibility with intra-class correlation coefficient ranging 
from 0.93 to 0.98. It shows that liver stiffness measurement using Fibroscan® is not 
dependent of the operator once the latter has been properly trained. 
4.2 Diagnosis of liver fibrosis  
4.2.1 Patients with chronic liver diseases 
As shown in Fig. 10, liver stiffness increases with the fibrosis stage obtained using liver 
biopsy. Liver stiffness has been shown to be closely related to fibrosis stage assessed by liver 
biopsy in patients suffering from chronic hepatitis C (Shaheen et al. 2007) and B (Marcellin 
et al. 2009), chronic cholestatic diseases (Corpechot et al. 2006), alcoholic liver disease (Melin 
et al. 2005; Mueller et al. 2010; Nguyen-Khac et al. 2008) and, recently, non-alcoholic fatty 
liver disease (Musso et al.). The most complete meta-analysis on the diagnosis accuracy of 
liver stiffness measured with Fibroscan® to assess liver fibrosis in patients with chronic liver 
disease of various etiology using liver biopsy as the gold standard (Friedrich-Rust et al. 
2008) compiled up to 38 studies (publications or abstracts) (Table 4). For the diagnosis of 
significant fibrosis, the average AUROC was 0.84 (0.82-0.86) (and 0.91 when adjusted for 
liver biopsy quality) with an optimal cut-off of 7.7 kPa. For the diagnosis of cirrhosis, the 
average AUROC was 0.94 (0.93-0.95) (and 0.99 when adjusted for liver biopsy quality) with 
an optimal cut-off of 13.0 kPa.  
 
 
Fig. 10. The stiffer the liver the faster the shear wave (white line). From 3.4 kPa in a healthy 
subject to 8.8 kPa and 38.8 kPa in a F2 and a F4 patients, respectively. The slope given by the 
shear wave front gets steeper as the stiffness increases. 
 
Fibrosis grade 
AUROC
(confidence interval)
AUROC corrected for  
liver biopsy quality 
F ≥ F2 0.84 (0.82 – 0.86) 0.91
F = 4 0.94 (0.93 – 0.95) 0.99
Table 4. Diagnosis accuracy of liver stiffness measured with Fibroscan® to assess liver 
fibrosis in patients with chronic liver disease of various etiology using liver biopsy as the 
gold standard. Compilation of 38 studies (publications or abstracts). 
(a) (b) (c) 
E = 3.4 kPa
F0 
E = 8.8 kPa
F2 
E = 38.8 kPa 
F4 
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4.2.2 General population 
Roulot (Roulot et al. 2010; Roulot et al. 2008) performed a study which aimed at detecting 
fibrosis in the general population. 1368 subjects attending a free check up in a medical center 
were measured. Liver biopsy was proposed to subjects (N=80) with stiffness values above 
8 kPa. 28 subjects accepted to go through liver biopsy. Interestingly, all of them had fibrosis 
and cirrhosis was found in all subjects with stiffness above 14.6 kPa. Among the 72 subjects 
between 8 kPa and 14.6 kPa : 45 were overweight with metabolic syndrome, 18 were 
alcoholic, 5 had HCV and 4 had HBV. 
4.3 Prognosis value 
4.3.1 Complication of cirrhosis 
In addition to being related to portal hypertension assessed by HVPG measurement (Bureau 
et al. 2008; Carrion et al. 2006; Vizzutti et al. 2008), liver stiffness was shown to be related to 
other complications of cirrhosis. In a study (Foucher et al. 2006) on 144 patients with biopsy 
proven cirrhosis or bridging fibrosis, liver stiffness measurement had an AUROC of 0.90, 
0.89, 0.71 and 0.88 for the detection of Child-Pugh score A versus BC, past history of ascites, 
presence of hepatocellular carcinoma and past history of ascites, respectively.  
4.3.2 Liver transplantation 
Rigamonti et al (Rigamonti et al. 2008) reported that liver stiffness accurately predicts 
fibrosis progression in liver transplanted patients with recurrent hepatitis C, suggesting that 
protocol liver biopsy might be avoided in patients with improved or stable transient 
elastography values during follow-up..  
4.3.3 Survival 
Vergniol et al (Vergniol et al.) followed 1457 patients (median 47.3 months) and 
demonstrated that the prognostic value of liver stiffness on survival was superior to that of 
liver biopsy. As a good predictive factor of survival, liver stiffness may help physician to 
evaluate earlier the severity of chronic liver diseases, to decide with stronger arguments of a 
liver transplantation or a portosystemic shunt and to evaluate more precisely the surgical 
risk of our cirrhotic patients. 
4.4 Treatment follow-up 
Fibroscan® was successfully used to assess liver fibrosis in patients during HCV or HBV 
therapy (Barreiro et al. 2006; Oliveri et al. 2008; Soriano et al. 2006). Ogawa et al (Ogawa et 
al. 2009) demonstrated that liver stiffness values measured by Fibroscan(r) may predict a 
progressively better clinical outcome for patients with successful virological and 
biochemical responses. Vergniol et al (Vergniol et al. 2009) suggested that Fibroscan(r) 
should be useful for assessing treatment efficacy in clinical trials of new drugs. 
Recently, Berends et al (Berends et al. 2007) reported that Fibroscan(r) accurately predicted 
the absence of significant liver fibrosis in methotrexate users. 
5. The pressure-stiffness-fibrosis sequence hypothesis 
5.1 Factors influencing liver stiffness 
As reported in the literature, liver stiffness is very well correlated with liver fibrosis. 
However studies showed that other factors influence liver stiffness. Several groups reported 
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that liver stiffness significantly increases during inflammatory episodes (Arena et al. 2008; 
Oliveri et al. 2008; Sagir et al. 2008). They showed that during several months monitoring, 
liver stiffness values paralleled those of ALT in patients with hepatitis exacerbation and 
observed a progressive decrease during antiviral therapy. Millonig (Millonig et al. 2009; 
Millonig et al. 2008) reported that mechanical cholestasis drastically and reversibly increases 
liver stiffness and that liver stiffness is influenced by central venous pressure and thus liver 
congestion, for example due to cardiac insufficiency. 
5.2 Physical point of view 
From a physical point of view, liver stiffness is obviously mainly driven by the liver 
extracellular matrix which provides structural support to the liver. However, since the liver 
is self-contained in a non extensible Glisson’s capsule, stiffness is definitively influenced by 
pressure that can be either hydrostatic or osmotic. The amount of collagen contained in the 
matrix yields a static stiffness. As shown in Fig. 11, on top of this static stiffness, hydrostatic 
and osmotic pressure effects will add a pressure-related stiffness term which results from 
body flood dynamics: blood flow, interstitial liquids, etc. On one hand, central venous 
pressure is directly related to hydrostatic pressure resulting from heart beating. On the other 
hand, flow of fluid from plasma to interstitial fluid is driven by osmotic pressure. During 
inflammatory episodes, accumulation of interstitial liquid and inflammatory infiltrate 
increases osmotic pressure. 
 
 
Fig. 11. Liver stiffness is composed of two components: static stiffness due to the 
extracellular matrix and dynamic stiffness linked to hydrostatic pressure and osmotic 
pressure. 
5.3 Molecular mechanism 
A study from Sakata (Sakata et al. 2004) supports the pressure-matrix-stiffness sequence 
hypothesis (Mueller & Sandrin 2010). Under this hypothesis, pressure results in increased 
mechanical stretching which induces transforming growth factor (TGF)-β synthesis in 
hepatic stellate cells, which is known to be highly expressed under profibrogenic 
conditions. Therefore, increased dynamic stiffness due to pressure induces mechanical 
stretches which stimulate the production of collagen (fibrotic tissue) which results in a 
static stiffness increase as if the liver was adapting its structure to inner body mechanical 
conditions.  
Among the numerous questions that still need to be answered on this very exciting subject, 
one of the more interesting may be the understanding of the respective roles of portal 
fibrosis and perisinusoidal fibrosis in liver stiffness. 
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6. Discussion 
Liver stiffness measurement using Fibroscan® has been studied in all major causes of 
chronic liver diseases: chronic hepatitis C, chronic hepatitis B, HIV – HCV co-infection, 
alcoholic liver disease (ALD), non alcoholic fatty liver disease (NAFLD), biliary disease, etc.  
6.1 The keys of Fibroscan® success and its limitations 
The success of liver stiffness measurement using Fibroscan® may be explained by several 
factors. First of al, it is a bedside procedure which lasts between 2 and 5 minutes and gives an 
immediate result. Second, the procedure is highly standardized with dedicated training which 
provides low operator dependence compared to ultrasound guided procedures, as an 
example. Third it offers new perspectives as liver stiffness is providing more information to 
physicians than fibrosis. Furthermore, it can be used for diagnosis, prognostic and follow-up. 
As any other procedure, liver stiffness measurement using Fibroscan® is having limitations. 
Main physical limitation is linked to the presence of ascites as liquids prevent the 
propagation of shear waves. As a consequence, shear waves are stopped before they can 
enter liver. Another limitation is related to obesity and more specifically to a large skin to 
liver capsula distance. In this case, ultrasound and shear wave aberration may occur and 
significantly reduce the success rate of liver stiffness measurements. A new probe, XL probe, 
was released to overcome this issue and demonstrated a significant improvement of the 
measurement success in obese patients.  
6.2 Liver stiffness is a clinically relevant parameter by itself 
In 2003, liver stiffness measured using Fibroscan® was introduced as an alternative to liver 
biopsy in order to assess liver fibrosis non-invasively. Nowadays liver stiffness is considered 
as a novel objective physical parameter that will eventually be used like arterial pressure or 
temperature. Primarily related by liver fibrosis, liver stiffness is influenced by venous 
pressure, inflammation and mechanical cholestatis. It is now part of the tools a physician 
may use to diagnose liver diseases. For this purpose, it should obviously be interpreted in 
the full context of clinical, imaging and laboratory findings (Fig. 12).  
 
 
Fig. 12. Liver stiffness should always be interpreted in the context of clinical, imaging and 
laboratory findings. 
Serum markers
Liver stiffness 
Imaging techniques 
HVPG
Liver biopsy
Endoscopy
Invasive
procedures
Non invasive 
procedures
Laparoscopy
www.intechopen.com
Non-Invasive Assessment of Liver Fibrosis by  
Vibration-Controlled Transient Elastography (Fibroscan®) 
 
309 
As explained earlier in this chapter, liver stiffness is not only affected by the liver matrix but 
also by pressure increase which may be attributed to several factors from congestion to 
inflammation. Furthermore, there are very disruptive elements that suggest that liver 
stiffness may not only be the consequence fibrosis deposits within the liver but also one of 
the causes of fibrogenesis as it has been demonstrated that hepatic stellate cells tend to 
generate fibrosis when they are under mechanical stress. For these reasons liver stiffness 
shall not be considered as a secondary endpoint; liver stiffness is a clinically relevant 
parameter by itself. 
6.3 Recent developments 
Even though liver stiffness provides an alternative to liver biopsy for fibrosis staging, it can 
not yield very important histologic features such as macrovesicular steatosis, ballooned 
hepatocytes, inflammation, etc. Recently, a new parameter, Controlled Attenuation 
Parameter (CAP), was designed to quantify liver steatosis using Fibroscan®. This 
measurement is performed at the exact same location where liver stiffness is measured and 
showed good performances for steatosis quantification (Sasso et al. 2010). 
The need for small animal non-invasive preclinical tools is growing. Obviously a Fibroscan® 
based instrumentation device adapted to small animal would have very interesting 
applications for the development of new drugs and for the study of drug-induced liver 
injury. Recently, Bastard (Bastard et al. 2011) demonstrated that VCTE™ can be adapted for 
small animal liver stiffness measurements.  
7. Conclusion 
Initially studied for its potential benefit for breast and prostate cancer, quantitative 
elastography eventually led to a promising diagnostic device in hepatology. The name 
Fibroscan® was invented at the time when liver stiffness measurement was intended to 
serve as an alternative to fibrosis staging using liver biopsy. Obviously, today the name 
Fibroscan® is misleading as liver stiffness has become a clinically relevant parameter by 
itself. Liver stiffness opened new possibilities in the field of hepatology: in routine and in 
research. These possibilities were made possible because of key advantages of non-invasive 
liver stiffness measurement with Fibroscan®. Among the important outcomes, the possible 
differentiation between early and advanced cirrhosis, the good prognostic value of liver 
stiffness on patient survival and the follow-up of patients undergoing treatments can be 
pointed out. Liver stiffness shall continue to be studied in many ways and will help 
physicians to better understand the natural history of liver diseases. With significant 
developments in the field of hepatology, for example the steatosis quantification, 
Fibroscan® may become the companion of hepatologists in their day to day clinical practice 
and research projects. 
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